MAIA Biotechnology, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
60.8M
on 2026-06-30, from 20.6M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
$11.2M
Agreement of 2026-05-14. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Cash
under 0.1 quarters
$0 on 2026-06-30 ÷ $5.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-03-02 | Public offering | 20,000,000 | $1.50 | $30.0M | 424B5 ↗ |
| 2025-12-16 | Private placement | 1,053,751 | not read | $1.3M | 8-K ↗ |
| 2025-10-13 | Private placement | 603,769 | not read | $737K | 8-K ↗ |
| 2025-09-29 | Private placement | 1,714,536 | not read | $2.2M | 8-K ↗ |
| 2025-05-27 | Private placement | 429,999 | not read | $645K | 8-K ↗ |
| 2025-04-14 | Private placement | 633,333 | not read | $950K | 8-K ↗ |
| 2025-02-24 | Private placement | 894,300 | not read | $1.3M | 8-K ↗ |
| 2025-02-18 | Private placement | 1,686,667 | not read | $2.5M | 8-K ↗ |
| 2024-12-09 | Private placement | 428,946 | $1.872 | $803K | 8-K ↗ |